BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Noven Pharmaceuticals Inc. 

11960 S.W. 144th Street

Miami  Florida  33186-5807  U.S.A.
Phone: 305-253-5099 Fax:


SEARCH JOBS










 Company News
Noven Pharmaceuticals Inc. Files Patent Infringement Lawsuit Against Actavis (ACT) 10/17/2014 10:44:35 AM
Noven Pharmaceuticals Inc. Announces Publication Of Exploratory Analyses From Pooled Phase 3 Results Of The Effects Of Brisdelle® (Paroxetine) Capsules On Weight And Sexual Function During Treatment Of Vasomotor Symptoms Associated With Menopause 10/14/2014 8:23:42 AM
Noven Pharmaceuticals Inc. Receives FDA Approval Of A New Indication With A New Dose For Minivelle® (Estradiol Transdermal System) 9/24/2014 11:12:58 AM
Noven Pharmaceuticals Inc. Appoints Krista Roberts As Vice President Of Operations 6/23/2014 8:50:55 AM
Pharma Firms Like Merck & Co., Inc. (MRK) And Noven Pharmaceuticals Inc. Flock To Miami 4/30/2014 8:16:07 AM
Noven Pharmaceuticals Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/17/2014 9:55:46 AM
Noven Pharmaceuticals Inc. Enters Co-Promotion Agreement With Shionogi, Inc. For Brisdelle™ (Paroxetine) Capsules 1/13/2014 12:08:31 PM
Noven Pharmaceuticals Inc. Release: First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies 11/5/2013 7:45:50 AM
Noven Pharmaceuticals Inc. Release: Data on Brisdelle™ (Paroxetine) Capsules, the First and Only FDA-Approved Non-Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting of The North American Menopause Society 10/2/2013 9:55:23 AM
FDA Panel Votes Against Approval of Noven Pharmaceuticals Inc.'s Menopause Drug 3/5/2013 8:00:41 AM
12345678910...